Yahoo Web Search

Search results

    • Merck to acquire EyeBio in potential $3B deal

      NJBIZ· 3 hours ago

      The agreement will bring EyeBio into Merck’s umbrella as a subsidiary. The privately held ophthalmology-focused biotechnology company is developing a pipeline of clinical ...